Here, we describe a case of an HIV-infected patient with right lower limb oedema that appeared after initiation of tenofovir and emtricitabine treatment. The patient was fully investigated by serial heart and vessel echo-Doppler examination. Oedema of the lower limb was attributed to a transient drug-induced fivefold increase in peripheral artery flow, which was induced by a reduction in peripheral arterial resistance. The possible mechanisms of disease are discussed.
Here, we describe a case of an HIV-infected patient with right lower limb oedema that appeared after initiation of tenofovir and emtricitabine treatment. The patient was fully investigated by serial heart and vessel echo-Doppler examination. Oedema of the lower limb was attributed to a transient drug-induced fivefold increase in peripheral artery flow, which was induced by a reduction in peripheral arterial resistance. The possible mechanisms of disease are discussed.
Previous cases of lower limb oedema have been reported in HIV-infected patients treated with ritonavir, lopinavir or stavudine [1] [2] [3] [4] . Here, we report a case of lower limb oedema with increased arterial flow induced by tenofovir and emtricitabine treatment.
The patient was a 35-year-old male who had tested positive for HIV 8 years ago, presumably from homosexual transmission. The patient had no drug addiction. At that time, the CD4 + T-cell count was 180 cells/ mm 3 and antiretroviral therapy (zidovudine, lamivudine and efavirenz) was initiated. The regimen was effective and achieved an undetectable viral load for the following 8 years and increased the CD4 + T-cell count to 400 cells/mm 3 . Because lipoatrophy developed on both legs, the nucleoside reverse transcriptase inhibitor backbone composed of zidovudine and lamivudine was replaced with tenofovir and emtricitabine. After 2 weeks, the patient developed painful right lower limb oedema. The oedema was not affected by position or day cycle. He had no previous personal or familial venous thromboembolic events. He reported no recent trauma, strenuous exercise, immobilization or surgery. On examination, the right thigh and calf were warm and tender, with a difference in circumference of 4 cm when compared with the left calf ( Figure  1 ). The skin was slightly erythematous, palpation of the whole limb was diffusely painful and the peripheral pulse examination was normal. The oedema was nonpitting and did not involve digits. Brachial blood pressure was 141/72 mmHg and heart rate was 110 beats/ min. There was no fever. Blood analysis yielded high levels of C-reactive protein (CRP; 115 mg/l, normal range <10) and creatine kinase (214 U/L, normal range <190). Haemoglobin (156 g/l), haematocrit (44%), white blood cell count (absolute count 4.4 G/l; repartition 70% neutrophils, 23% lymphocytes, 5% monocytes and 1 % eosinophils), serum creatinine (71 µmol/l), thyroid stimulating hormone (1.13 mU/l), albumin (42 g/l) and lactate levels (1.12 mmol/l) were within the normal range. There was no detectable proteinuria. Two pairs of aerobic and anaerobic blood cultures remained negative. Echo-Doppler examination excluded lower limb deep and superficial vein thrombosis or extrinsic venous compression. There was no venous insufficiency or postplebitic syndrome. Soft tissue mass, haematoma, popliteal cyst, either intact or ruptured, were all excluded by meticulous B-mode soft tissue examination. Arterial flow was measured by echo-Doppler at rest and was found to be dramatically increased in the four limbs, reaching 1,364 ml/min in the right and 821 ml/min in the left common femoral arteries (normal rest flow 250 ±50 ml/min). Diastolic flow was markedly increased as a consequence of reduced arterial resistance (Figure 2 was also measured in the superior mesenteric artery (850 ml/min). Echocardiography showed normal left ventricular contractility, with an ejection fraction of 65% and absence of valvular disease. The calculated cardiac output was slightly increased at 6,160 ml/min, which was caused by tachycardia (110 beats/min), and normal ejection volume (56 ml, measured by biplane volumetric method). A stage 1 left ventricular diastolic dysfunction was observed (impaired relaxation with prolonged isovolumetric relaxation time and inversion of the early passive/active filling ratio (E/A ratio). Tenofovir and emtricitabine were immediately stopped and replaced by zidovudine and lamivudine. After three days, calf erythema, pain and arterial blood flow were dramatically decreased, and returned to normal within 6 weeks ( Table 1) . The short delay between drug exposure and oedema, as well as the full normalization of the clinical picture after drug withdrawal, strongly support the implication of tenofovir and emtricitabine as a trigger of this oedema. These drugs induced a peripheral and splanchnic increase in blood flow, with slight compensatory tachycardia and unchanged ejection volume. Analysis of proximal arterial velocities showed high diastolic flow, which is suggestive of decreased peripheral resistance. The mechanisms by which antiretroviral drug could reduce vascular resistance remains hypothetical. An infection, either systemic or localized in the limb, could have similar effects on the peripheral resistance and could explain the high CRP levels; however, in this case, there was no fever, no clinically obvious infection and evolution was good without antibiotics. High CRP levels were observed in two cases of inflammatory oedema of the legs described by Lascaux et al. [2] and an inflammatory aspect of the swollen leg was reported in other similar previous reports; however, an infection could not be indentified in any of these cases.
A syndrome of immune restoration with development of a cytokine-mediated high blood flow might also have been induced, but this seems unlikely in our patient because immunity was already restored over the past 8 years. Other mechanisms responsible for high cardiac output or oedema, such as anaemia, hyperthyroidism and liver cirrhosis, were excluded in this case. The clinical aspect of the oedema, its rapid extension and recovering, and the absence of initial morning relief were all evidence against a lymphedema.
The clinical picture observed here suggests the contribution of a drug-related diffuse arteriolar vasodilatation. Two mechanisms could be postulated. First, the drugs could induce oedema by direct vasodilatation of peripheral arteriole or by opening arteriovenous shunts. The subsequent pre-capillary pressure increase might provoke oedema. This inadequate vasodilation might be accounted for by the various effects of antiviral therapy observed on endothelial function in HIV-infected patients and healthy volunteers. It has long been postulated that endothelial dysfunction observed in HIVinfected patients precedes premature atherosclerosis [5] and is a consequence of the metabolic disturbance of protease inhibitors, mainly dyslipidaemia, insulin resistance and abdominal fat redistribution [6] ; however, the switch from another protease inhibitor to atazanavir did not result in endothelial function improvement despite an improvement in lipid profile [7] . Moreover, indinavir induced a dramatic impairment of endotheliumdependent vasodilatation in healthy patients [8] , whereas in treatment-naive HIV-infected patients, initiation of three different class-sparing antiviral regimens induced a significant improvement in flow-mediated dilation, probably consecutive to the reduction in viral load [9] . In our case, we did not perform any endothelial function testing and cannot therefore conclude whether endothelial-dependant or -independent dilation was impaired by tenofovir and emtricitabine. The second postulated mechanism could be an adequate endothelial-mediated peripheral vasodilation that is consecutive to a local toxic phenomenon. The initial lesion could be a result of direct drug toxicity to the muscle cells, such as a mitochondrial toxicity, with subsequent impairment of the respiratory cycle, local ischaemia and inflammation. This hypothetical mechanism would explain the release of muscle enzymes, the increase in CRP and even the transient lactataemia that was observed in other cases [4] . In this model, the arterial vasodilation would be a physiological adaptive response of blood supply to the damaged tissue.
In conclusion, it seems that a wider range of antiretroviral drugs than previously thought might lead to this particular haemodynamic pattern. Because tenofovir and emtricitabine are now widely used in HIV-infected patients, physicians should be aware of this side effect. In case of lower or upper limb oedema, exclusion of a deep-vein thrombosis might not be sufficient among HIV-infected patients and a measure of the resting arterial flow by echo-Doppler should be performed.
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